Skip to content

Author

Zoltán Szállási

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinoma

Extensive validation will be needed to convert PATH-ORACLE from a prognostic biomarker to a predictive biomarker that could be used to prioritize stage IB patients for adjuvant targeted therapy, chemotherapy, or immune checkpoint inhibitor therapy with or without liquid biopsy-based monitoring.

O. Kilim, O. Pipek, Z. Sztupinszki et al. · 0 citations
Open access Aug 2026

Crosstalk between S-nitrosylation and glycation defines a metabolic vulnerability in liver and renal cancers

It is demonstrated that pharmacological inhibition of the glyoxalase system—the major pathway for MGO detoxification—restores drug sensitivity in patient-derived cells and xenograft models, revealing a context-dependent metabolic vulnerability in AKR1A1 loss conditions.

Chiara Pecorari, Mojca Bratina, Evelyn Gonzalez et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.